Michael Girardi MD
Professor, Dermatology, Yale University School of Medicine
Join to View Full Profile
15 York StNew Haven, CT 06510
Phone+1 203-785-4632
Fax+1 203-785-3315
Dr. Girardi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Yale-New Haven Medical CenterResidency, Dermatology, 1994 - 1997- Yale-New Haven Medical CenterInternship, Internal Medicine, 1992 - 1993
Yale School of MedicineClass of 1992
Brown UniversityBS & BA, Biology & Computer Science, Magna Cum Laude, 1984 - 1988
Certifications & Licensure
CT State Medical License 1997 - 2026
American Board of Dermatology Dermatology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
- Elected Member The American Society for Clinical Investigation, 2008
- Fellow (FAAD) American Academy of Dermatology
Clinical Trials
- A Sunscreen Based on Bioadhesive Nanoparticles Start of enrollment: 2017 Jul 17
- A Study of ABT-199 (Venetoclax) for Cutaneous T Cell Lymphoma (CTCL) Start of enrollment: 2020 Jan 15
Publications & Presentations
PubMed
- Syringotropic mycosis fungoides with clinical and histologic features of necrobiosis lipoidica diabeticorum.Mónica Torres-Piwinski, Kacie R Carlson, Gauri Panse, Michael Girardi
JAAD Case Reports. 2025-10-01 - Weekly dosing schedule of brentuximab vedotin is well tolerated in mycosis fungoides/Sézary syndrome.Megan Lee, Molly Schiffer, Iris Isufi, Scott F Huntington, Mina L Xu
British Journal of Haematology. 2025-09-18 - 11 citationsEvaluation of Benzene Presence and Formation in Benzoyl Peroxide Drug Products.Kaury Kucera, Nicola Zenzola, Amber Hudspeth, Mara Dubnicka, Wolfgang Hinz
The Journal of Investigative Dermatology. 2025-05-01
Journal Articles
- Clarification Regarding Noninferiority and a Discussion of Model Selection and Treatment Effects in Observational Research—ReplyMichael Girardi, MD, JAMA Dermatology
- Evaluation of Lymph Node Ratio Association with Long-Term Patient Survival After Surgery for Node-Positive Merkel Cell CarcinomaMichael Girardi, Shayan Cheraghlou, JAMA
Authored Content
- Clarification Regarding Noninferiority and a Discussion of Model Selection and Treatment Effects in Observational Research—ReplyJune 2020
Press Mentions
2023 ‘Top Doctors’ List Features Over 250 Yale Medicine PhysiciansMay 3rd, 2023- Connecticut Magazine’s 2023 “Top Doctors” Issue Recognizes 82 Smilow Cancer Hospital and Yale Cancer Center PhysiciansMay 1st, 2023
- For the Best Melanoma Prognosis, Location MattersApril 2nd, 2021
- Join now to see all
Grant Support
- Training in Investigative DermatologyYALE UNIVERSITY1975–2026
- Local Immunoregulation Of CarcinogenesisNational Cancer Institute2010–2011
- T Cell Regulation Of Cutaneous MalignancyNational Cancer Institute2003–2007
- TCR DNA Immunization For 2b411 T Cell LymphomaNational Institute Of Arthritis And Musculoskeletal And Skin Diseases1998–2002
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
